Background: Peptidyl-prolyl isomerase H (PPIH) is a member of the cyclophilin protein family, which functions as a molecular chaperone and is involved in the splicing of pre-mRNA. According to reports, the malignant progression of HCC related to hepatitis B virus (HBV) is tightly associated with RNA-binding proteins. Nevertheless, there is no research on PPIH expression or its function in the occurrence and progression of HCC.
Results: We are the first to reveal that the mRNA and protein levels of
Ppih
are substantially overexpressed in HCC, as the outcomes show. A significant correlation existed between enriched expression of
Ppih
within HCC and more advanced, poorly differentiated, and TP53-mutated tumors.
Conclusion: These findings, which suggest that
Ppih
may serve as a predictive biomarker for people with HCC, serve as a starting point for further investigation into the function of
Ppih
in the progression of carcinogenesis.
Methods: Accordingly, we utilized clinical samples and bioinformatics analysis to assess
Ppih’s
mRNA, protein expression, and gene regulatory system in HCC. Additionally, Wilcoxon signed-rank testing and logistic regression were utilized to inspect the association between clinicopathological factors and
Ppih
. Clinical pathological traits linked to overall survival (OS) among HCC patients were examined via TCGA data via Cox regression and the Kaplan-Meier approach. Additionally, via TCGA data collection, gene set enrichment assessment was also conducted.